Triple-negative breast cancer (TNBC) is a clinically aggressive subtype associated with poorer survival outcomes. We examined the patterns and trends in neoadjuvant chemotherapy (NACT) use, pathologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback